Onconova Therapeutics, Inc. (ONTX) Financials
Stock symbol ONTX is outdated, potentially delisted? Maybe it is available on other exchange?
ONTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 27.0 million | 12.5 million |
| June 30, 2023 | 30.5 million | 11.6 million |
| March 31, 2023 | 35.1 million | 12.2 million |
| Dec. 31, 2022 | 39.4 million | 11.1 million |
ONTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -4.5 million | 360000 |
| June 30, 2023 | -4.5 million | 273000 |
| March 31, 2023 | -4.5 million | 336000 |
| Dec. 31, 2022 | -3.9 million | 330000 |
ONTX Net Income
No data available :(
ONTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 25.2 million | - | - |
| June 30, 2023 | 29.7 million | - | - |
| March 31, 2023 | 34.2 million | - | - |
| Dec. 31, 2022 | 38.8 million | - | - |
ONTX Shares Outstanding
ONTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 14000 | 2.5 million | 2.7 million | - |
| June 30, 2023 | - | 2.5 million | 2.2 million | - |
| March 31, 2023 | - | 4.1 million | 2.1 million | - |
| Dec. 31, 2022 | - | 3.8 million | 2.0 million | - |
ONTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | 57000 | 5000 |
| June 30, 2023 | 57000 | 4000 |
| March 31, 2023 | 56000 | 3000 |
| Dec. 31, 2022 | 56000 | 4000 |
ONTX
Price: $1
52 week price:
Earnings Per Share: -0.96 USD
P/E Ratio: -0.68
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 74400
Ebitda: -6.7 millionMarket Capitalization: 17.6 million